FIVASA 500 mg, suppository 30 suppositories
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Suppository30 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FIVASA 500 mg, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- film(s) thermosoudé(s) PVC polyéthylène de 30 suppositoire(s)
- Marketing authorisation holder
- TILLOTTS PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Mar 2002
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60080218CIP73588117CIP133400935881175Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEsuppositoire | 500 mg · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.